Clinical Trial Update: Safety of Tuberculosis Vaccine, MVA85A, Administered by the Aerosol Route and the Intradermal Route [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety of the tuberculosis vaccine MVA85A when administered by aerosol and intradermal routes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• MVA85A vaccine (Recombinant Modified Vaccinia Ankara expressing antigen 85A)

Snippet

Sponsor: University of Oxford | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED